Dermatology & clinical

A randomized controlled trial analyzing nonthermal atmospheric plasma for the treatment of verruca vulgaris in pediatric patients

C. L. Walker, C. N. Shope, L. A. Andrews, K. M. Atherton, T. Beck, G. Santa Lucia, G. Fridman, P. C. Friedman, C. H. Cotton, L. Wine Lee

Journal of the American Academy of Dermatology, 2025, 92(1): 46–50
DOI: 10.1016/j.jaad.2024.07.1522 (opens in a new tab) Cited by 3

Abstract

Background: Verruca vulgaris (VV) is a common viral disease in children. Treatment options are often not well tolerated in children due to pain or adverse effect risk. Nonthermal atmospheric plasma (NTAP), which generates reactive oxygen/nitrogen species, is well tolerated and without adverse effects. Objective: Determine efficacy of NTAP as compared to standard of care (SOC) therapy for VV in children. Methods: This prospective open-label study randomized lesions 1:1 to receive NTAP or SOC (cryotherapy). Patients were treated at 4-week intervals for a maximum of 3 treatments. They were evaluated 4 weeks postfinal treatment for sustained response. Primary outcome was lesion response. Results: One hundred twelve VV lesions in 14 patients were enrolled. Patients were mostly White (92.9%) males (71.4%) with mean age of 9.5 [±2.5] years. Responses of SOC- and NTAP-treated lesions, respectively, included no response (5.4%, 7.1%); partial response (33.9%, 41.1%); and complete resolution (60.7%, 51.8%; P value = .679). Patients were more likely to report pain in SOC lesions post-treatment (P value < .001). No significant adverse events (AEs) occurred. Limitations: Limitations include single-site, maximum of 3 treatments, and short post-treatment follow-up. Conclusion: NTAP is an efficacious, safe intervention for treatment of VV in children.

How to cite

C. L. Walker, C. N. Shope, L. A. Andrews, K. M. Atherton, T. Beck, G. Santa Lucia, G. Fridman, P. C. Friedman, C. H. Cotton, L. Wine Lee (2025). A randomized controlled trial analyzing nonthermal atmospheric plasma for the treatment of verruca vulgaris in pediatric patients. Journal of the American Academy of Dermatology, 92(1): 46–50. https://doi.org/10.1016/j.jaad.2024.07.1522